Patient Involvement in Outcome Measures for Psoriatic Arthritis

Psoriatic arthritis (PsA) is a heterogeneous inflammatory arthritis with a varied clinical phenotype. There has been considerable international collaboration over recent years to develop and prioritise appropriate disease domains and outcome measures to capture all aspects of this complex disease. I...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current rheumatology reports 2014-05, Vol.16 (5), p.418-418, Article 418
Hauptverfasser: Tillett, William, Adebajo, Ade, Brooke, Mel, Campbell, Willemina, Coates, Laura C., FitzGerald, Oliver, Gossec, Laure, Helliwell, Philip, Hewlett, Sarah, James, Jana, Minnock, Patricia, Reast, Aisling, O’Sullivan, Dennis, de Wit, Maarten, McHugh, Neil
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Psoriatic arthritis (PsA) is a heterogeneous inflammatory arthritis with a varied clinical phenotype. There has been considerable international collaboration over recent years to develop and prioritise appropriate disease domains and outcome measures to capture all aspects of this complex disease. It has been recognised that patient-reported measures and physician assessments are complementary and, when used together, allow an improved reflection of disease burden. Taking this concept one step further, the experience in rheumatoid arthritis has demonstrated benefits of incorporating the patient perspective in the development of outcome measures. We report a systematic review demonstrating (1) that there has been little incorporation of the patient perspective in the development of outcome measures and domains in PsA, (2) the proceedings from the preliminary patient involvement in outcome measures for PsA (PIOMPSA) meetings, and (3) a proposed roadmap for improving patient involvement.
ISSN:1523-3774
1534-6307
DOI:10.1007/s11926-014-0418-7